key: cord-0953804-9r862cye
authors: Guerrero-Esteban, Tamara; Gutiérrez-Sánchez, Cristina; Villa-Manso, Ana M.; Revenga-Parra, Mónica; Pariente, Félix; Lorenzo, Encarnación
title: Sensitive SARS-CoV-2 detection in wastewaters using a carbon nanodot-amplified electrochemiluminescence immunosensor
date: 2022-05-13
journal: Talanta
DOI: 10.1016/j.talanta.2022.123543
sha: 5cce7ae611d17a77a81f0a12ea99e17037b19bb4
doc_id: 953804
cord_uid: 9r862cye

Given the great utility that having fast, efficient and cost-effective methods for the detection of SARS-CoV-2 in wastewater can have in controlling the pandemic caused by this virus, the development of new dependable and specific SARS-CoV-2 coronavirus sensing devices to be applied to wastewater is essential to promote public health interventions. Therefore, herein we propose a new method to detect SARS-CoV-2 in wastewater based on a carbon nanodots-amplified electrochemiluminescence immunosensor for the determination of the SARS-CoV-2 Spike S1 protein. For the construction of the immunosensor, N-rich carbon nanodots have been synthetized with a double function: to contribute as amplifiers of the electrochemiluminescent signal in presence of [Ru(bpy)3]2+ and as antibody supports by providing functional groups capable of covalently interacting with the SARS-CoV-2 Spike S1 antibody. The proposed ECL immunosensor has demonstrated a high specificity in presence of other virus-related proteins and responded linearly to SARS-CoV-2 Spike S1 concentration over a wide range with a limit of detection of 1.2 pg/mL. The immunosensor has an excellent stability and achieved the detection of SARS-CoV-2 Spike S1 in river and urban wastewater, which supplies a feasible and reliable sensing platform for early virus detection and therefore to protect the population. The detection of SARS-CoV-2 Spike S1 in urban wastewater can be used as a tool to measure the circulation of the virus in the population and to detect a possible resurgence of COVID-19.

Coronavirus disease (COVID-19) that causes the severe acute respiratory syndrome is 42 produced by the SARS-CoV-2 virus and was declared a pandemic on March 13, 2020. This interest. It has become the leading cause of death worldwide and is also causing a major 45 socio-economic crisis [1] . Millions of people have been infected due to SARS-CoV-2, also 46 causing the death of many of them [2] . For this reason, the scientific community is making 47 great efforts to deepen the study of this pathogen [3-7] and develop rapid tests to make quick currently being employed [23, 24] . Therefore, although efforts have never stopped to explore 77 faster and more sensitive methods, there is still a high demand for sensitive, selective, 78 affordable, rapid and user-friendly tests to detect SARS-CoV-2 timely and accurately. proteins indicative of disease. In addition, it has been shown that the performance of ECL 89 biosensors is greatly improved through using nanomaterials resulting in promising breeding 90 strategies in ECL biosensor applications [27] , in particular, in terms of sensitivity and 91 stability. However, the application of ECL devices for the detection of SARS-CoV-2 is still 92 in its infancy. As far as we know, the only ECL biosensor previously described [28] is based 93 on the detection of RdRp-COVID gene, but no ECL immunosensor for the detection of 94 SARS-CoV-2 Spike protein, despite the fact that it induces the maximum immune response,

[19] has been described yet.

On the other hand, most of SARS-CoV-2 biosensors developed, in particular electrochemical 97 immunosensors, have been focused on diagnosis and applied to the detection of SARS-CoV-98 2 in body fluids, such as nasal and saliva [29] . Few early works applied immunological-based 99 methods to detect viruses in raw wastewater have been described to date [30] . However, there 100 is also evidence that the virus is present in urban wastewater and its detection in these samples 101 is a useful tool already known for the epidemiological surveillance of viruses that is being The ability of urban wastewater surveillance to detect mild or asymptomatic cases is one of 108 its main advantages and can be an early warning tool for prompt identification of the presence would be especially powerful as they can create an early warning system that can inform 112 authorities of a potential outbreak. 113 Hence, the development of sensitive, cost-effective, and rapid methods for SARS-CoV-2 114 detection in wastewater are essential for widespread, successful implementation of 115 wastewater-based epidemiology for SARS-CoV-2. 116 In this work, the development of a reliable, sensitive and disposable ECL immunosensor 117 based on CNDs, which act as antibody support and ECL amplifiers, for rapid determination 118 of S1 in various types of water, including urban wastewater, is described. All the solutions were prepared using deionized water obtained from a Millipore Milli-Q 

Dried CNDs powder was used to obtain X-ray diffraction (XRD) spectra using an X-pert 155 PRO Theta/2Theta diffractometer from Panalytical. Subsequently, the S1/BSA/S1-Ab/CNDs/SPCE was placed into the ECL cell and the 

We have developed a sensitive ECL immunosensor for the detection of S1 based on the use 219 of CNDs as antibody supports and ECL amplifiers. Scheme 1 depicts the different stages 220 followed in the immunosensor development. First, the electrode was modified with the 221 synthesized N-rich CNDs. The precursors for CNDs synthesis have been wisely chosen, since 222 is crucial for the development of this immunosensor that the obtained CNDs are rich in 223 aromatic primary amines. These functional groups will allow CNDs to be electrografted on 224 carbon electrodes. In addition, CNDs are used as platform for immobilizing the S1-Ab 225 through crosslinking reactions between carboxylic acids present at their surface and primary 226 amines of S1-Ab after activation with EDC and NHS. To avoid unspecific adsorptions the 227 electrode surface was covered by BSA. Finally, the sensing of the S1 is based on the change 228 in the ECL signal produced by the luminophore [Ru(bpy)3] 2+ due to the antigen-antibody 229 recognition event that takes place at the electrode surface. nucleus with a predominantly amorphous structure (Fig. 1B) .

The functional groups present in the synthetized CNDs were elucidated from the FTIR 253 spectra of the precursors used in the synthesis and the CNDs (Fig. 1C) . CNDs spectrum 405 nm is observed when the excitation wavelength is set at 320 nm (Fig. 1D, inset) . 265 Moreover, as the excitation wavelength increases from 320 to 500 nm a decrease in the 266 emission intensity is observed. This characteristic behaviour of CNDs, is mainly due to 267 radiation scattering effects due to the presence of nanoparticles of different sizes [42] . CNDs electrografting on the SPCE surface was carried out cycling the potential between 0.0 277 V and -0.9 V in 0.5 M HCl. Fig. 2A shows the cyclic voltammograms. It can be seen, that in 278 the first cathodic scan, a reduction process appears with a clearly defined cathodic peak at - In addition, if CNDs/SPCE is used as electrochemical platform in an ECL system using 308 [Ru(bpy)3] 2+ as luminophore, the ECL signal at the CNDs nanostructured electrode is higher 309 than that observed at bare electrode as can be observed in Fig. 3(b) . Therefore, CNDs In order to obtain the highest ECL response, we studied first the effect of the diazotization 318 time. As can be seen (Fig. 2E) , the ECL signal increases on increasing the diazotization immobilization of S1-Ab to the antigen is achieved. 336 We use the ECL signal to control the successive steps followed in the immunosensor 337 development and as the immunosensor response. The most frequently used ECL-active label 338 is [Ru(bpy)3] 2+ , because its ECL can be generated in aqueous solutions with a suitable co-339 reactant and because the emission is intense and fairly stable [37]. Fig. 3 shows the ECL 340 response obtained at each step. The bare SPCE exhibits an almost negligible ECL signal (a) 341 compared to the response after CNDs are electrografted on its surface (b), since, as we 342 described above, CNDs act as amplifying agents of the ECL signal. After S1-Ab 343 immobilization on the electrografted CNDs and BSA addition to prevent nonspecific 344 interactions, there is a considerable increase in the ECL signal (c). We believe that this effect 345 is due to the presence of amino and hydroxyl groups that constitute the antibody that may 346 behave as co-reactants. Capture of 20 pg/mL S1 causes a significant decrease in the ECL 347 signal (d), due to a significant steric hindrance suffered by the ECL probe [Ru(bpy)3] 2+ after 348 antibody-antigen complex formed. This effect has been previously observed on others ECL 349 immunosensors [53]. This major change in the ECL response allows the detection of S1.

350 Therefore, in order to assess that the ECL signal change observed can be correlated with the 351 S1 recognition event, we carried out different controls. First, the established S1-Ab 352 immobilization protocol was performed without using EDC/NHS activation. The 353 immunosensor response to 20.0 pg/mL S1 is presented in bar diagram (e) of Fig. 3 . It is 354 appreciated a decrease in the ECL signal compared to the response of the immunosensor 355 prepared using activation (see bar d of Fig. 3) . This result agrees well with the fact that in the 356 absence of activation, fewer covalent bonds between the antibody and CNDs are formed and 357 those formed are not stable. Thus, there are few antibody molecules on the immunosensor 358 J o u r n a l P r e -p r o o f platform to recognize the protein (S1), which results in a decrease in the ECL signal response.

A similar ECL signal response is observed (see bar f of Fig. 3 ) in a second control performed, 360 in which the immunosensor was developed following the protocol established, but without 361 the addition of antibody (S1-Ab). These results confirm the main role that a stable antibody 362 immobilization plays in the final immunosensor response.

Lastly, we also verified that the ECL signal decrease is due to the specific immunological 364 recognition of S1 and the crucial role of the antibody specificity. For this purpose, we used 365 the HER2 antibody (Anti-HER2), which recognizes the protein HER2 but not S1, instead of 366 the S1-Ab. As can be seen in bar (g) of Fig. 3 , in this case the ECL response to 20 pg/mL S1 367 is the same that obtained before recognition of the S1 (see bar c in Fig. 3) . No decrease of 368 the ECL signal is observed since there is not any immunological recognition event. The main experimental variables that may affect the ECL-based immunosensor response, 373 such as pH, [Ru(bpy)3] 2+ concentration, scan rate, besides the concentration of S1-Ab, the 374 immobilization time of S1-Ab and incubation time of S1, were evaluated and optimized. The 375 selected criterion was the largest ratio between the ECL immunosensor response in the 376 absence (S0) or in the presence (S) of 20 pg/mL of S1 (Fig. S2) . The highest ECL response 377 was obtained using 0.1 M PB (pH 8.0), 2.0×10 -3 M [Ru(bpy)3] 2+ , a scan rate 0.03 V/s with 378 200 ng/mL of S1-Ab, and immobilization times of 60 and 30 min for the S1-Ab and the S1, The analytical parameters calculated for the method proposed in this work are shown below.

The previously optimized experimental conditions have been considered. Fig. 4A shows that 387 the ECL immunosensor response decreases to increasing amounts of S1. A linear dependence 388 (r 2 = 0.992) between ECL signal vs. the logarithm of S1 standard concentrations was found The reproducibility of the responses obtained with three different immunosensing devices 396 prepared in the same way was also evaluated. The ECL signals obtained for 20 pg/mL S1 397 standard solution, provided relative standard deviation (RSD) of 5.6%.

In addition, the stability of the immunosensor was studied for 700 s applying consecutive 96% of the initial value (Fig. 4C) . The storage stability of the immunosensor was also 402 evaluated. After storage at 4 °C in wet chamber for 44 days, a loss of ECL response with 403 respect to the initial of 8% was observed (Fig. S3) .

J o u r n a l P r e -p r o o f Also, it has been carried out a study of the selectivity of the immunosensor against several 405 proteins, such as SARS-CoV-2 Nucleocapsid, MERS-CoV Spike S1 and Influenza A virus 406 H1N1. As shown in Fig. 4D , no significant responses are observed for any of proteins 407 assayed, except the small signal observed in the case of the Influenza A virus H1N1, 408 confirming the immunosensor is quite specific to S1 protein. The response to 20 pg/mL S1 409 is also included as reference.

The analytical characteristics of the developed ECL-based immunosensor were compared 411 with other S1 immunosensors that have been described so far (Table S1 ). We have not been 412 able to make a comparison with other ECL-based immunosensors, because as far as we know 413 this is the first ECL immunosensor for S1 prepared to date. From the comparison, we can CoV-2 has been evaluated to directly determine S1 in river and urban wastewater samples.

Water samples from a river and from rural areas (Waste A and B) were analyzed and 428 compared to results obtained with tap water. The amount of S1 present in all water samples 429 analyzed was no detectable (n.d.) by direct analysis with the ECL method developed, neither 430 with ELISA kit. In Fig. S4 , the ECL response without normalizing can be directly 431 appreciated. Thus, the amount of protein in these samples was below the LOD. The 432 recoveries were evaluated by spiking the samples with 40.0 pg/mL S1 obtaining results close 433 to 100% (see Table 1 ). However, direct determination of S1 in urban wastewater from 434 different locations (Waste C, D and E) gives values presented in Table 1 . The results agree 435 well to those obtained by a conventional ELISA methodology, demonstrating the 436 applicability of the immunosensor. Table 1 . Determination of S1 in river and wastewater samples with the developed ECL-based 439 immunosensor and with the colorimetric ELISA kit as a comparative method (n=3).

Immunosensor ELISA S1 Added S1 Found Recovery S1 RSD S1 and also the covalent immobilization of the S1-Ab on their surface providing great stability. 

The S1 concentration was 20 pg/mL. The ECL measurements were done at 0.030 V/s scan 482 rate. (e), (f ) and (g) were recorded after addition of S1 20.0 pg/mL. 

The Lancet Infectious 492 Diseases